Advanced Medical Solutions expecting first-half revenue growth.
Advanced Medical Solutions said on Monday that it expects first-half revenue of about £115.2m, up from £110.8m a year earlier, despite some orders slipping into early July and de-stocking linked to the expansion of direct sales in Europe.
Advanced Medical Solutions Group
20 July 2026 14:20:22
Source: Sharecast
The AIM-traded firm said the period also faced a strong comparator after order phasing from a key strategic partner boosted the Advance Closure division in the first half of 2025.
The group said the integration of Peters Surgical and Syntacoll remained on track and reiterated that full-year 2026 EBITDA was expected to meet current market forecasts.
Chief executive Chris Meredith said AMS remained confident in its long-term prospects, supported by its strengthened product portfolio and pipeline of opportunities.
At 1400 BST, shares in Advanced Medical Solutions Group were up 0.4% at 280.12p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
N/A
ISIN:
N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes
Compare our accounts
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
